XML 63 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Plan (Tables)
12 Months Ended
Dec. 31, 2022
Equity Plan  
Schedule of stock option activity under the equity plans

    

    

    

Weighted

    

 

Weighted

Average

 

Average

Remaining

Aggregate

 

Number

Exercise

Contractual

Intrinsic

 

Total Stock Options

of Shares

Price

Life (Years)

Value

 

Outstanding at January 1, 2022

 

2,584,632

$

10.00

Granted

 

387,000

$

11.12

Exercised

 

(305,880)

$

6.70

Forfeited or expired

 

(138,579)

$

12.34

Outstanding at December 31, 2022

 

2,527,173

$

10.44

 

5.52

$

7,497,913

Vested or expected to vest

 

2,375,543

 

5.52

$

7,048,038

Exercisable at December 31, 2022

 

1,900,047

 

4.48

$

6,333,749

Schedule of information related to the equity Plan

    

 

December 31, 

2022

2021

2020

Intrinsic value of options exercised

$

1,674,072

$

1,543,711

$

2,258,245

Cash received from option exercise

$

2,049,587

$

1,469,255

$

1,713,737

Tax benefit realized from option exercises

$

180,414

$

153,745

$

63,124

Weighted average fair value of options granted

$

2.22

$

2.31

$

1.15

Schedule of assumptions used to estimate the fair value of each option grant on the date of grant

December 31, 

2022

    

2021

2020

Expected life in months(1)

 

72

72

72

Volatility(1)

 

31

%  

33

%  

29

%  

Weighted average risk-free interest rate(2)

 

2.89

%  

1.10

%  

0.53

%  

Expected dividends(3)

 

4.68

%  

4.32

%  

5.71

%  

(1)

The expected life of employee stock options represents the weighted average period the stock options are expected to remain outstanding based on historical experience. Volatility is based on the historical volatility of the stock price over the same period of the expected life of the option.

(2)

Based on the U.S. Treasury constant maturity interest rate with a term consistent with the expected life of the option granted.

(3)

Each grant’s dividend yield is calculated by annualizing the most recent quarterly cash dividend and dividing that amount by the market price of the Company’s common stock as of the grant date

Schedule of restricted stock activity under the equity plans

Weighted

 

Average Grant

 

Number

Date Fair

 

Total Restricted Stock Award

    

of Shares

    

Value

 

Nonvested shares at January 1, 2022

 

298,566

$

11.03

Granted

 

238,811

$

11.16

Vested

 

(252,081)

$

11.81

Forfeited or expired

(31,805)

$

11.23

Nonvested shares at December 31, 2022

 

253,491

$

11.05